---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000050"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:44:32.845231+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Clover Health Reports FY2025 Revenue Up 40% to $1.9B, Guides to First GAAP Net Income Profitability in FY2026

## Summary
- Full year 2025 total revenues of $1.9 billion, up 40% year-over-year; GAAP net loss of $86 million.
- Adjusted EBITDA of $22 million for 2025; Medicare Advantage membership grew 38% to 113,803.
- Full year 2026 guidance: revenues $2.81B-$2.92B, GAAP net income $0M-$20M, Adjusted EBITDA $50M-$70M.
- Expects first full year of GAAP Net Income profitability in 2026 driven by improving cohort economics and Clover Assistant.
- 2026 average Medicare Advantage membership guided to 154,000-158,000, representing 46% growth at midpoint.

## SEC filing metadata
- accession: 0001801170-26-000050
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/0001801170-26-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/clov-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000050
- JSON: https://secwatch.observer/filing/0001801170-26-000050.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.